Short Interest In SciClone Pharmaceuticals Drops 17.6%

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 462,133 share decrease in total short interest for SciClone Pharmaceuticals, Inc. (SCLN), to 2,167,158, a decrease of 17.58% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for SCLN at the 10/31/2016 settlement increased to 257,570, as compared to 213,661 at the 10/14/2016 report. That brought "days to cover" down to 8.41, a 31.63% decrease from the 12.31 days to cover calculated at the previous short interest data release.

The below chart shows the historical "days to cover" for SCLN at previous short interest release dates:

START SLIDESHOW:
Top 25 S.A.F.E. Dividend Stocks »

Loading+chart++2016+TickerTech.com

A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where SCLN had been shorted as a hedge.

The chart below shows the one year performance of SCLN shares, versus its 200 day moving average. Looking at this chart, SCLN's low point in its 52 week range is $7.37 per share, with $15.03 as the 52 week high point — that compares with a last trade of $9.60.

SciClone Pharmaceuticals, Inc. Chart

According to the ETF Finder at ETF Channel, SCLN makes up 1.11% of the iShares U.S. Pharmaceuticals ETF (IHE) which is higher by about 1.8% on the day Thursday.

More from Stocks

GE Is Too Opaque, Too Diversified and Too Poorly Managed: Doug Kass Insider

GE Is Too Opaque, Too Diversified and Too Poorly Managed: Doug Kass Insider

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Google's YouTube in Hot Water Again Over Ads on Inappropriate Content

Google's YouTube in Hot Water Again Over Ads on Inappropriate Content

Should Tesla Nominate a New CEO Not Named Elon Musk?

Should Tesla Nominate a New CEO Not Named Elon Musk?